ULURU

United States
Grandfield, Oklahoma, United States, 75001

Company profile

ULURU company profile

ULURU is a specialty pharmaceutical company, engages in the research, development, and commercialization of wound care and mucoadhesive film products in the United States and internationally. The company’s products are based on patented Nanoflex and OraDisc drug delivery technologies. Its products include Altrazeal, a transforming powder dressing for the treatment of various wounds, such as partial-thickness burns, donor sites, and abrasions, as well as surgical, acute, and chronic wounds; Aphthasol and Aptheal for the treatment of canker sores; OraDisc A for the treatment of oral conditions, which rely upon the use of medications formulated as gels and pastes that are applied to lesions in the mouth; and OraDisc B, a mucoadhesive disc product for the treatment and management of oral pain. The company was founded in 1987 and is based in Addison, Texas.

Business identity

Contact email
[email protected]
Phone number
2149055130
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
1987-01-01, Year

Headquarters

Postal code
75001
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
7
Total equity funding
$5.1M
Last funding
Post IPO Equity / $2.2M / 2023-09-18
Last equity funding
Post IPO Equity / $2.2M
Articles
5
Exited on
2012-04-02

Founders and investors

No public relation records are available.